Myovant Sciences Ltd
MYOV
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.62B
Close$
$34.23
26.9% upside
Current Fair Value
26.9% upsideUndervalued by 26.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.62 Billion |
|---|---|
| Enterprise Value | $2.86 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.22 |
| Beta | 2.15 |
| Outstanding Shares | 96,859,000 |
Return
| Return on Equity | 32.93% |
|---|---|
| Return on Assets | -45.54% |
| Return on Invested Capital | -93.11% |
Valuation & Multiples
| P/E Ratio | -12.18 |
|---|---|
| PEG | 132.8 |
| Price to Sales | 8.99 |
| Price to Book Ratio | -4.5 |
| Enterprise Value to Revenue | 7.54 |
| Enterprise Value to EBIT | -19.45 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | -0.87 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data